12/30/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): Only 5% of Doctors Find Statistics by Ministry of Health on Average Salaries Believable
The vast majority of doctors (92%) consider the official statistics of the Ministry of Health and Rosstat on average salaries not reliable, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Around 37% of the respondents consider the official statistics to be completely unreliable, believing that the figures provided by Ministry of Health are “several times” higher than the real ones.
Between January and September 2019, Russia exported 32.5 bln RUB worth of pharmaceutical drugs (customs duties included), which is in monetary terms (rubles) 22.4% higher than that of the same in 2018. The two-digit growth rates have been registered since 2018 (the dynamics in 2018 were +16.1%). The dynamics in physical terms (units) are +6.7%, with 653 mln units.
12/18/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): Excessive Workloads and Healthcare System Failures Are Main Causes of Medical Errors
35% of doctors believe that the main cause of medical errors are “excessive workloads”, followed by “failures of the healthcare system”, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. However, excessive workloads are also a direct result of the improper organization of the healthcare system.
The Russia market of veterinary products consists of two main segments: households’ purchases and agricultural complexes and farms’ purchases. The volume of households’ purchases amounted to 18.1 bln RUB (retail prices, VAT included) in October 2019. Pet medicines account for 92% of the volume in monetary terms, while livestock medicines – for around 8%.
12/10/2019 Database Update: Pharmaceutical Drug Import for Clinical Trials to Russia (September 2019)
Between January and September 2019, Russia imported 532.3 thousand units, 13.1 bln RUB worth of pharmaceutical drugs for clinical trials (CT) (customs clearance prices, VAT included). The dynamics in physical terms (units) are only +0.4%. The dynamics in monetary terms (rubles) are much higher, +9.8%. The importers were most active in Q3 2019.